According to The Insight Partners' research, the global IVF services market was valued at US$ 13,496.29 million in 2019 and is projected to be worth US$ 31,613.7 million by 2027, growing at 11.6% CAGR during 2020–2027. Increasing incidence of infertility, rising number of fertility clinics and infertility services with government support, and growing number of product launches and developments are the key factors credited for market expansion.

The fertility rate is steadily declining globally owing to various factors, such as hormonal changes, age-related complications, and genetic defects. Moreover, chlamydia diseases cause about 4–5 million infections annually in the US. If left untreated, it can cause infertility in both sexes. Thus, the declining fertility rate leads to a significant increase in the demand for in vitro fertilization (IVF) services that help determine the fertility window in males and females.

Assisted reproductive technology (ART) now produces more than 50,000 babies per year in the US through 330,000 IVF procedures. Various government initiatives and changes in the legal system are driving the demand for assisted reproduction procedures in clinics, thus promoting the IVF services market.

However, the high procedural cost of reproductive techniques is hindering the market growth.